Immunology Terms Starting With S

Secondary Immune Response is the accelerated, amplified adaptive immune response generated when the immune system encounters an antigen it has previously recognized, driven by long-lived memory B and T cells that persist after the primary response.

During a primary response, naive lymphocytes take seven to fourteen days to generate detectable antibody titers, whereas a secondary response can produce protective antibody levels within one to three days of re-exposure. Memory B cells undergo rapid clonal expansion and secrete high-affinity IgG antibodies, reflecting the affinity maturation and class switching that occurred during the germinal center reaction of the primary response. Their T cell counterparts carry lower activation thresholds than naive T cells, requiring less co-stimulation to proliferate and execute effector functions.

This immunological memory is the biological basis of vaccination: the Salk polio vaccine, introduced in 1955, primed memory responses that protected recipients against subsequent poliovirus exposure without causing disease.

Serology is the scientific study and clinical use of blood serum to detect antibodies, antigens, or complement components, providing diagnostic information about past or current infections, immune status, and blood group compatibility.

Serological tests include enzyme-linked immunosorbent assays, western blots, hemagglutination inhibition assays, complement fixation tests, and lateral flow immunoassays, each with different sensitivity, specificity, and clinical applications. Seroprevalence studies measure the proportion of a population with detectable antibodies against a specific pathogen, providing population-level data on infection history and herd immunity thresholds. Blood bank operations depend on serological ABO and Rh typing to prevent hemolytic transfusion reactions, which can be fatal when incompatible red cells are transfused.

During the COVID-19 pandemic, large-scale serology surveys conducted in 2020 and 2021 revealed that infection rates in many communities were three to ten times higher than confirmed case counts suggested, reshaping public health estimates of population exposure.

SKIV2L is an RNA helicase gene encoding the catalytic subunit of the cytoplasmic SKI complex, which degrades aberrant cytoplasmic RNAs, and whose loss-of-function mutations cause an immunodysregulatory condition marked by inflammatory bowel disease, liver disease, and immune dysregulation.

SKIV2L encodes the Ski2 ortholog, the catalytic helicase subunit of the trimeric SKI complex, which threads aberrant RNAs including stalled ribosomal mRNAs into the cytoplasmic exosome for 3-prime-to-5-prime degradation. When SKIV2L function is lost, unprocessed RNA species accumulate in the cytoplasm and activate innate RNA-sensing pathways, particularly the RIG-I/MAVS axis, driving inappropriate type I interferon and inflammatory cytokine production. This chronic innate immune activation underlies the trichohepatoenteric syndrome phenotype, which includes intractable diarrhea, woolly hair, liver disease, and immunodeficiency.

Fewer than 100 cases of SKIV2L-related trichohepatoenteric syndrome had been reported in the medical literature as of 2023, making it one of the rarest monogenic inflammatory bowel conditions known.

Spleen is a fist-sized secondary lymphoid organ located in the left upper abdomen that filters blood, removes aged red blood cells, and mounts immune responses against blood-borne pathogens.

The spleen contains two functionally distinct compartments: white pulp, consisting of lymphoid follicles and periarteriolar lymphoid sheaths that house B and T cells respectively, and red pulp, where resident macrophages filter senescent red blood cells and opsonized pathogens from the circulation. Blood-borne antigens are captured and presented by marginal zone macrophages and dendritic cells, making the spleen the primary site of adaptive immune responses against bacteremia. Each day, roughly 20 milliliters of aged red blood cells are destroyed in the human spleen, and the iron recovered from hemoglobin is recycled for new erythrocyte production.

Beyond filtration, the spleen harbors a reservoir of monocytes, estimated at about half the body’s total monocyte pool in mice, that mobilize rapidly to sites of acute tissue injury such as myocardial infarction.

Superantigen is a microbial protein that activates a large fraction of T cells simultaneously by crosslinking MHC class II molecules on antigen-presenting cells directly to the variable region of the T cell receptor beta chain, bypassing normal peptide-specific antigen recognition.

Conventional antigens activate roughly 0.001 percent of circulating T cells through peptide-MHC recognition, whereas superantigens engage conserved framework regions of specific TCR Vbeta families and can stimulate 5 to 25 percent of all T cells at once. This massive polyclonal activation drives a cytokine storm characterized by high levels of TNF-alpha, IL-1, and IL-6, producing the fever, hypotension, and multi-organ dysfunction of toxic shock syndrome. Staphylococcus aureus produces at least 23 distinct superantigen toxins, including toxic shock syndrome toxin-1 and the staphylococcal enterotoxins responsible for food poisoning.

Streptococcus pyogenes produces streptococcal pyrogenic exotoxins that similarly cause streptococcal toxic shock syndrome, with case fatality rates reaching 30 to 70 percent in severe cases.

Systemic Lupus is a chronic autoimmune disease characterized by production of autoantibodies against nuclear antigens, deposition of immune complexes in multiple organs, and recurrent inflammatory flares affecting the skin, joints, kidneys, and nervous system.

SLE arises from failure of both central and peripheral tolerance to nuclear antigens, including double-stranded DNA and histones, generating pathogenic autoantibodies that form immune complexes depositing in kidney glomeruli, dermal vessels, and synovium. Lupus nephritis develops in 50 to 60 percent of SLE patients and is the leading cause of long-term morbidity, with up to 10 percent of affected patients progressing to end-stage renal disease within ten years of diagnosis. Plasmacytoid dendritic cells activated by nucleic acid-containing immune complexes produce large quantities of type I interferon, which amplifies autoreactive B and T cell responses and sustains the inflammatory cycle.

SLE affects women roughly nine times more often than men, and disease onset peaks between ages 15 and 45, implicating sex hormones and X-linked gene dosage in disease susceptibility.